ITTO991009A0 - Antagonisti iii del recettore ccr-3. - Google Patents

Antagonisti iii del recettore ccr-3.

Info

Publication number
ITTO991009A0
ITTO991009A0 IT99TO001009A ITTO991009A ITTO991009A0 IT TO991009 A0 ITTO991009 A0 IT TO991009A0 IT 99TO001009 A IT99TO001009 A IT 99TO001009A IT TO991009 A ITTO991009 A IT TO991009A IT TO991009 A0 ITTO991009 A0 IT TO991009A0
Authority
IT
Italy
Prior art keywords
ccr
receptor antagonists
iii
antagonists iii
receptor
Prior art date
Application number
IT99TO001009A
Other languages
English (en)
Inventor
Daniel Harry Rogers
John Saunders
John Patrick Williams
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ITTO991009A0 publication Critical patent/ITTO991009A0/it
Publication of ITTO991009A1 publication Critical patent/ITTO991009A1/it
Application granted granted Critical
Publication of IT1307900B1 publication Critical patent/IT1307900B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT1999TO001009A 1998-11-20 1999-11-19 Antagonisti iii del recettore ccr-3. IT1307900B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10929798P 1998-11-20 1998-11-20

Publications (3)

Publication Number Publication Date
ITTO991009A0 true ITTO991009A0 (it) 1999-11-19
ITTO991009A1 ITTO991009A1 (it) 2001-05-19
IT1307900B1 IT1307900B1 (it) 2001-11-19

Family

ID=22326918

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999TO001009A IT1307900B1 (it) 1998-11-20 1999-11-19 Antagonisti iii del recettore ccr-3.

Country Status (27)

Country Link
US (1) US6166015A (it)
EP (1) EP1131288A1 (it)
JP (1) JP3593037B2 (it)
KR (1) KR20010086045A (it)
CN (1) CN1158256C (it)
AR (1) AR023707A1 (it)
AU (1) AU763960B2 (it)
BR (1) BR9915520A (it)
CA (1) CA2350903A1 (it)
CO (1) CO5140119A1 (it)
CZ (1) CZ20011760A3 (it)
DE (1) DE19955794A1 (it)
ES (1) ES2158814B1 (it)
FR (1) FR2786185A1 (it)
GB (1) GB2343893B (it)
HU (1) HUP0104364A2 (it)
ID (1) ID29067A (it)
IL (1) IL143226A0 (it)
IT (1) IT1307900B1 (it)
MA (1) MA26762A1 (it)
NO (1) NO20012411D0 (it)
PE (1) PE20001403A1 (it)
PL (1) PL348375A1 (it)
TR (1) TR200101398T2 (it)
UY (1) UY25811A1 (it)
WO (1) WO2000031032A1 (it)
ZA (1) ZA200103942B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6316623B1 (en) * 1998-08-21 2001-11-13 Isis Pharmaceuticals, Inc. Ethylenediamine compound libraries
JP3421323B2 (ja) 1998-11-20 2003-06-30 エフ.ホフマン−ラ ロシュ アーゲー ピペリジンccr−3受容体拮抗薬
CA2373942A1 (en) * 1999-05-18 2000-11-23 Teijin Limited Remedies or prophylactis for diseases in association with chemokines
CA2378499A1 (en) * 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists
ES2276706T3 (es) * 1999-12-08 2007-07-01 Teijin Limited Antagonistas del receptor ccr5 de aminas ciclicas.
BR0114321A (pt) * 2000-09-29 2003-07-01 Glaxo Group Ltd Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto
EP1324990B1 (en) 2000-09-29 2014-10-29 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases
ES2292530T3 (es) 2000-12-19 2008-03-16 F. Hoffmann-La Roche Ag Pirrolidinas sustituidas como antagonistas del receptor ccr-3.
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
GB0117387D0 (en) * 2001-07-17 2001-09-05 Novartis Ag Organic compounds
JP2005502700A (ja) * 2001-09-13 2005-01-27 エフ.ホフマン−ラ ロシュ アーゲー Ccr−3受容体アンタゴニストv
US7067549B2 (en) * 2001-12-31 2006-06-27 Actelion Pharmaceuticals Ag Pyrrolidone carboxamides
GB0207432D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207443D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207436D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207439D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0212355D0 (en) * 2002-05-29 2002-07-10 Glaxo Group Ltd Novel compounds
EP1531822B1 (en) 2002-06-12 2009-08-05 ChemoCentryx Inc 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
CN1665506A (zh) 2002-07-02 2005-09-07 霍夫曼-拉罗奇有限公司 作为ccr-3受体拮抗剂ⅸ的2,5-取代的嘧啶衍生物
WO2004028530A1 (en) * 2002-09-26 2004-04-08 Bristol-Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
ATE440835T1 (de) 2003-03-06 2009-09-15 Glaxo Group Ltd Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
EP1601665A2 (en) 2003-03-07 2005-12-07 Glaxo Group Limited Urea derivatives
GB0305426D0 (en) * 2003-03-08 2003-04-16 Glaxo Group Ltd Novel compounds
RU2366655C2 (ru) 2003-03-14 2009-09-10 Оно Фармасьютикал Ко., Лтд. Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
WO2004092169A1 (ja) 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
EP1680408A2 (en) * 2003-10-24 2006-07-19 F. Hoffmann-La Roche Ag Ccr3 receptor antagonists
US7435830B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7435831B2 (en) 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
RU2403237C2 (ru) * 2004-05-14 2010-11-10 Эмисфире Текнолоджис, Инк. Составы и смеси для доставки активных агентов
MXPA06013252A (es) * 2004-05-14 2007-02-28 Emisphere Tech Inc Compuestos y composiciones para suministrar agentes activos.
US8143404B2 (en) 2004-09-13 2012-03-27 Ono Pharmaceutical Co., Ltd Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
US7968539B2 (en) 2005-02-17 2011-06-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University Quinoline derivatives and uses thereof
EP1889622A4 (en) 2005-05-31 2009-12-23 Ono Pharmaceutical Co SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
WO2007011292A1 (en) * 2005-07-21 2007-01-25 Astrazeneca Ab N-benzyl-morpholine derivatives as modulators of the chemokine receptor
KR100743617B1 (ko) * 2005-08-25 2007-07-27 주식회사 알에스텍 고광학순도를 갖는 키랄 3-히드록시 피롤리딘 및 그유도체를 제조하는 방법
BRPI0616150A2 (pt) * 2005-09-22 2011-06-07 Sanofi Aventis derivados de amino-alquil-amida como lìquidos receptores de ccr3
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500879A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
EP2657235A1 (en) 2005-10-28 2013-10-30 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
WO2007058322A1 (ja) 2005-11-18 2007-05-24 Ono Pharmaceutical Co., Ltd. 塩基性基を含有する化合物およびその用途
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2007132846A1 (ja) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. 保護されていてもよい酸性基を含有する化合物およびその用途
JP5245827B2 (ja) 2006-07-31 2013-07-24 小野薬品工業株式会社 スピロ結合した環状基を含有する化合物およびその用途
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CN101906060B (zh) * 2010-05-06 2012-07-04 爱斯医药科技(南京)有限公司 N-取代的3-氨甲基吡咯烷的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JPH01117860A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
JPH02104572A (ja) * 1988-10-13 1990-04-17 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
US5214055A (en) * 1990-05-18 1993-05-25 Adir Et Compagnie Aminopiperidine 4-oxo-4H-chromen-2-yl compounds
FR2662162B1 (fr) * 1990-05-18 1995-01-20 Adir Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5254569A (en) * 1991-01-14 1993-10-19 The Du Pont Merck Pharmaceutical Company (Amidomethyl)nitrogen heterocyclic analgesics
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
FR2679906B1 (fr) * 1991-07-31 1995-01-20 Adir Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993003725A1 (en) * 1991-08-20 1993-03-04 Smithkline Beecham Plc 5-ht4 receptor antagonists
JPH06212757A (ja) * 1993-01-19 1994-08-02 Ribaa Kentetsu Kk ソリ型運搬治具による折板屋根葺き工法
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
JPH11140276A (ja) * 1997-11-11 1999-05-25 Sumitomo Chem Co Ltd 多官能シアン酸エステル樹脂組成物および樹脂封止型半導体装置
SK285729B6 (sk) * 1997-11-18 2007-07-06 Teijin Pharma Limited Zlúčenina derivátov cyklických amínov a jej použitie

Also Published As

Publication number Publication date
JP2002530374A (ja) 2002-09-17
ZA200103942B (en) 2002-08-15
CN1331677A (zh) 2002-01-16
KR20010086045A (ko) 2001-09-07
BR9915520A (pt) 2001-07-17
EP1131288A1 (en) 2001-09-12
NO20012411L (no) 2001-05-16
GB2343893A (en) 2000-05-24
ID29067A (id) 2001-07-26
US6166015A (en) 2000-12-26
IT1307900B1 (it) 2001-11-19
CZ20011760A3 (cs) 2001-12-12
IL143226A0 (en) 2002-04-21
ITTO991009A1 (it) 2001-05-19
PE20001403A1 (es) 2000-12-15
AU1382500A (en) 2000-06-13
JP3593037B2 (ja) 2004-11-24
CA2350903A1 (en) 2000-06-02
AU763960B2 (en) 2003-08-07
NO20012411D0 (no) 2001-05-16
DE19955794A1 (de) 2000-05-31
AR023707A1 (es) 2002-09-04
GB9927227D0 (en) 2000-01-12
FR2786185A1 (fr) 2000-05-26
TR200101398T2 (tr) 2001-09-21
PL348375A1 (en) 2002-05-20
MA26762A1 (fr) 2004-12-20
ES2158814B1 (es) 2002-03-16
CO5140119A1 (es) 2002-03-22
GB2343893B (en) 2002-01-09
HUP0104364A2 (hu) 2002-04-29
ES2158814A1 (es) 2001-09-01
WO2000031032A1 (en) 2000-06-02
CN1158256C (zh) 2004-07-21
UY25811A1 (es) 2001-07-31

Similar Documents

Publication Publication Date Title
IT1307900B1 (it) Antagonisti iii del recettore ccr-3.
IT1307062B1 (it) Antagonisti iii del recettore ccr-3.
IT1308657B1 (it) Antagonisti ii del recettore ccr-3.
TR199801594A3 (tr) CCR-3 reseptör antagonistleri.
DZ2320A1 (fr) Antagonistes de récepteurs de vitronectine.
CY2010003I2 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
ZA975671B (en) IL-8 receptor antagonists.
ZA977301B (en) IL-8 receptor antagonists.
ZA9810685B (en) Thrombin receptor antagonists.
ATE272632T1 (de) Muskarin-rezeptor antagonisten
EP0684823A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS.
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
NO20016053L (no) IL-8 reseptor-antagonister
DZ2322A1 (fr) Antagonistes de récepteurs de vitronectine.
NO20016052L (no) IL-8-reseptor-antagonister
DK1180028T3 (da) IL-8-receptorantagonister
ZA200109627B (en) IL-8 receptor antagonists.
ZA200201780B (en) Vitronectin receptor antagonists.
DK1131291T3 (da) 4-aroyl-piperidin-CCR-3-receptorantagonister III
ZA200110203B (en) IL-8 receptor antagonists.
ZA200110205B (en) IL-8 receptor antagonists.
TR199601082A3 (tr) Entegrin reseptör antagonistleri.
MXPA03005581A (es) Pirrolidinas substituidas como antagonistas del receptor ccr-3.
ZA991884B (en) Vitronectin receptor antagonists.
ZA975743B (en) IL-8 receptor antagonists.